Of particular relevance to glioblastoma is the finding that PFKFB3:PFKFB4 mRNA ratios are of prognostic value to high grade glioma, with increasing PFKFB4 levels correlating unfavorably with patient survival [15]. This evidence concerns the gene PFKFB4 and central nervous system cancer.